Steven Reichling Accelerate Diagnostics, Inc (AXDX) insider trading activity

Steven Reichling is Chief Financial Officer of Accelerate Diagnostics, Inc. Currently has a direct ownership of 142,370 shares of AXDX, which is worth approximately $185,081. The most recent transaction as insider was on Mar 13, 2023, when has been sold 4,708 shares (Common Stock) at a price of $0.49 per share, resulting in proceeds of $2,306. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 142K

0% 3M change

0% 12M change

Total Value Held $185,081

STEVEN REICHLING Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 13 2023	SELL Open market or private sale	$2,306 $0.49 p/Share	4,708 Reduced 3.2%	142,370 Common Stock
Mar 13 2023	BUY Exercise of conversion of derivative security	-	9,438 Added 6.03%	147,078 Common Stock
Mar 08 2023	SELL Open market or private sale	$29,505 $0.47 p/Share	62,778 Reduced 31.32%	137,640 Common Stock
Mar 08 2023	BUY Exercise of conversion of derivative security	-	123,600 Added 38.15%	200,418 Common Stock
Feb 13 2023	SELL Open market or private sale	$2,893 $0.6 p/Share	4,823 Reduced 5.91%	76,818 Common Stock
Feb 13 2023	BUY Exercise of conversion of derivative security	-	9,439 Added 10.36%	81,641 Common Stock
Jan 13 2023	SELL Open market or private sale	$3,263 $0.69 p/Share	4,730 Reduced 6.15%	72,202 Common Stock

Jan 13 2023	BUY Exercise of conversion of derivative security	-	9,439 Added 10.93%	76,932 Common Stock
Aug 22 2022	BUY Open market or private purchase	$6,950 $1.39 p/Share	5,000 Added 6.9%	67,493 Common Stock
Apr 28 2022	SELL Open market or private sale	$29,317 $0.98 p/Share	29,915 Reduced 32.37%	62,493 Common Stock
Apr 26 2022	BUY Exercise of conversion of derivative security	-	57,736 Added 38.45%	92,408 Common Stock
May 13 2021	SELL Open market or private sale	$56,128 $6.76 p/Share	8,303 Reduced 19.32%	34,672 Common Stock
May 12 2021	BUY Exercise of conversion of derivative security	-	27,392 Added 38.93%	42,975 Common Stock
Jan 27 2021	SELL Open market or private sale	$381,250 $15.25 p/Share	25,000 Reduced 65.27%	13,300 Common Stock
Jan 27 2021	BUY Exercise of conversion of derivative security	$74,500 $2.98 p/Share	25,000 Added 39.49%	38,300 Common Stock
Jan 26 2021	SELL Open market or private sale	$311,375 $12.5 p/Share	24,910 Reduced 65.19%	13,300 Common Stock
Jan 26 2021	BUY Exercise of conversion of derivative security	$74,232 $2.98 p/Share	24,910 Added 39.46%	38,210 Common Stock
Jan 25 2021	SELL Open market or private sale	$219,029 $10.55 p/Share	20,761 Reduced 60.95%	13,300 Common Stock
Jan 25 2021	BUY Exercise of conversion of derivative security	$61,868 $2.98 p/Share	20,761 Added 37.87%	34,061 Common Stock
Dec 17 2020	SELL Open market or private sale	$6,331 $7.37 p/Share	859 Reduced 5.22%	15,583 Common Stock
Dec 16 2020	BUY Exercise of conversion of derivative security	-	3,142 Added 16.04%	16,442 Common Stock
Nov 09 2020	SELL Open market or private sale	$373,626 $9.5 p/Share	39,329 Reduced 74.73%	13,300 Common Stock
Nov 09 2020	BUY Exercise of conversion of derivative security	$117,200 $2.98 p/Share	39,329 Added 42.77%	52,629 Common Stock

Steven Reichling

Chief Financial Officer

Tucson, AZ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AXDX shares.

Notify only if

Value

Insider Trading

Get notified when an Accelerate Diagnostics, Inc insider buys or sells AXDX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Accelerate Diagnostics, Inc

Track Activities on AXDX

Account